
Triatussic 12.5mg/2mg/100mg Syrup
Marketer
Wanbury Ltd
Salt Composition
Phenylpropanolamine (12.5mg) + Chlorpheniramine Maleate (2mg) + Dextromethorphan Hydrobromide (100mg)
Overview Triatussic 12.5mg/2mg/100mg Syrup
Combiflu 12.5 mg/2 mg/100 mg Syrup is a multi-component medication indicated for managing dry cough. It provides relief from allergic manifestations including nasal discharge, nasal congestion, sneezing, lacrimation, and sinus congestion. Combiflu 12.5 mg/2 mg/100 mg Syrup should be administered as directed by your physician, with or without food. Dosage is tailored to individual needs and response. Continue treatment as prescribed; premature discontinuation may lead to symptom recurrence or condition exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common adverse effects include nausea, dyspepsia, sleep disturbances, palpitations, and hypertension. These are generally transient and self-limiting. Report any concerns to your physician immediately. Drowsiness and dizziness may occur; avoid driving or activities requiring alertness until effects are known. Alcohol consumption should be avoided due to potential additive sedative effects. Self-medication is strongly discouraged; never share your prescription. Keep out of children's reach. Adequate hydration is recommended during treatment. Individuals with hepatic impairment should inform their physician before commencing treatment to ensure appropriate dosage adjustment. Pregnant or lactating women should consult their physician prior to use.
Uses of Triatussic 12.5mg/2mg/100mg Syrup
Persistent, unproductive cough
Major Benefits of Triatussic 12.5mg/2mg/100mg Syrup:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Always consult the product label for complete instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Triatussic 12.5 mg/2 mg/100 mg Syrup can be taken with or without food; however, consistent timing is recommended.
Common Side effects of Triatussic 12.5mg/2mg/100mg Syrup:
- Nausea
- Upset stomach
- Insomnia (difficulty in sleeping)
- Palpitations
- Sleepiness
- High blood pressure
How to use Triatussic 12.5mg/2mg/100mg Syrup:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always consult the product label for administration guidelines. Use a measuring cup for accurate dosing and take orally. Ensure the syrup is well-shaken before each use. Triatussic 12.5 mg/2 mg/100 mg Syrup can be ingested with or without food; however, consistent timing is recommended.
How Triatussic 12.5mg/2mg/100mg Syrup works:
Combiflu-12.5/2/100 Syrup, a triple-action cough remedy, combines phenylpropanolamine, chlorpheniramine maleate, and dextromethorphan hydrobromide to alleviate dry coughs. Phenylpropanolamine's decongestant properties constrict nasal blood vessels, easing stuffiness. Chlorpheniramine maleate, an antihistamine, combats allergy symptoms such as rhinorrhea, lacrimation, and sneezing. Dextromethorphan hydrobromide, a centrally acting antitussive, suppresses coughs by dampening brain-stem cough reflexes.
SAFETY ADVICE
AlcoholCAUTION
Using Triatussic 12.5 mg/2 mg/100 mg Syrup with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Triatussic 12.5 mg/2 mg/100 mg Syrup during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against the possible dangers before recommending its use. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Triatussic 12.5 mg/2 mg/100 mg Syrup with breastfeeding are lacking. Seek medical advice.
DrivingUNSAFE
Using Triatussic 12.5 mg/2 mg/100 mg Syrup might impair driving ability due to potential adverse reactions.
KidneySAFE IF PRESCRIBED
The use of Triatussic 12.5 mg/2 mg/100 mg Syrup in patients with kidney disease appears to pose minimal risk. Preliminary evidence indicates dose modification might be unnecessary for this patient group. However, physician consultation is recommended.
LiverUNSAFE
Individuals with hepatic impairment should not take Triatussic 12.5 mg/2 mg/100 mg Syrup due to potential safety risks. Medical advice is recommended.
What if you forget to take Triatussic 12.5mg/2mg/100mg Syrup :
Should you forget a dose of Triatussic 12.5 mg/2 mg/100 mg Syrup, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triatussic 12.5mg/2mg/100mg Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
